CA Patent

CA2491655A1 — Method for reducing c-rective protein levels with non-antibacterial tetracycline formulations

Assigned to Montefiore Medical Center · Expires 2004-01-22 · 22y expired

What this patent protects

The present invention is for a method for decreasing C-reactive protein levels (CRP) in a mammal in need thereof. The method comprises administering an effective amount of a non-antibacterial tetracycline formulation, to the mammal. In one embodiment, the non-antibacterial tetrac…

USPTO Abstract

The present invention is for a method for decreasing C-reactive protein levels (CRP) in a mammal in need thereof. The method comprises administering an effective amount of a non-antibacterial tetracycline formulation, to the mammal. In one embodiment, the non-antibacterial tetracycline formulation is a non-antibacterial amount of an antibacterial tetracycline. In another embodiment, the non-antibacterial tetracycline formulation is a non-antibacterial tetracycline.

Drugs covered by this patent

Patent Metadata

Patent number
CA2491655A1
Jurisdiction
CA
Classification
—
Expires
2004-01-22
Drug substance claim
No
Drug product claim
No
Assignee
Montefiore Medical Center
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.